Novacyt S.A. (NVYTF)
OTCMKTS · Delayed Price · Currency is USD
0.5101
0.00 (0.00%)
At close: Oct 28, 2025
Novacyt Market Cap
Novacyt has a market cap or net worth of $37.4 million as of November 3, 2025. Its market cap has decreased by -28.21% in one year.
Market Cap
37.40M
Enterprise Value
20.23M
Revenue
26.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.51
Market Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 30.50M to 37.40M, an increase of 22.64%. That is a compound annual growth rate of 1.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 36.60M | -16.75% |
| Dec 31, 2024 | 43.97M | -20.95% |
| Dec 29, 2023 | 55.62M | -40.03% |
| Dec 30, 2022 | 92.74M | -73.63% |
| Dec 31, 2021 | 351.75M | -58.45% |
| Dec 31, 2020 | 846.58M | 7,591.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 660.18M |
| Glass House Brands | 563.78M |
| Northwest Biotherapeutics | 377.06M |
| Silence Therapeutics | 338.20M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 302.09M |
| CytoDyn | 297.30M |